Back to results
US 2020/0347008 A1Published application
Methods of manufacturing benzoquinoline compounds
AssigneeAuspex Pharmaceuticals, Inc.
InventorChengzhi Zhang
Life of this patent
Estimating the term…
Abstract
The present invention relates to new methods of manufacturing benzoquinoline inhibitors of vesicular monoamine transporter 2 (VMAT2), and intermediates thereof.
Claims32
The (cis)-d6-Tetrabenazine having a diastereomeric purity of at least 99% and having a deuterium enrichment of no less than about 10%.
A process of preparing a (cis)-d6-tetrabenazine having a diastereomeric purity of at least 99% and having a deuterium enrichment of no less than about 10%, comprising:
- reacting d6-6,7-dimethoxy-3,4-dihydroisoquinoline, or a salt thereof,
- d6-6,7-dimethoxy-3,4-dihydroisoquinoline with a salt of 2-acetyl-N,N,N,4-tetramethyl-1-pentanaminium:
- 2-acetyl-N,N,N,4-tetramethyl-1-pentanaminium salt wherein X is halogen, alkyl sulfate, alkyl sulfonate, halosulfonate, perhaloalkyl sulfonate, aryl sulfonate, alkylaryl sulfonate, dialkyloxonium, alkylphosphate, or alkyl carbonate;
- and an optional base;
- in the presence of one or more solvents;
- for a period of time and at a temperature sufficient to produce the (cis)-d6-tetrabenazine having a diastereomeric purity of at least 99%, based on high performance liquid chromatography.
3 more elements
Dependencies are inferred from the claim text.